Scarica l'app Stockscreener
5.43
1.27%
-0.07
Dopo l'orario di chiusura:
5.79
0.36
+6.63%
Precedente Chiudi:
$5.50
Aprire:
$5.49
Volume 24 ore:
540.20K
Relative Volume:
0.45
Capitalizzazione di mercato:
$694.31M
Reddito:
$193.01M
Utile/perdita netta:
$-12.15M
Rapporto P/E:
-60.33
EPS:
-0.09
Flusso di cassa netto:
$454.00K
1 W Prestazione:
+7.52%
1M Prestazione:
+11.73%
6M Prestazione:
+58.31%
1 anno Prestazione:
-20.50%
Intervallo 1D:
$5.37
$5.5316
Intervallo di 1 settimana:
$4.895
$5.61
Portata 52W:
$2.37
$7.30
Cytek Biosciences Inc Stock (CTKB) Company Profile
Nome
Cytek Biosciences Inc
Settore
Industria
Telefono
(877) 922-9835
Indirizzo
47215 LAKEVIEW BOULEVARD, FREMONT
Confronta CTKB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
5.43 | 703.26M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
126.18 | 220.91B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.38 | 146.24B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.21 | 140.64B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
98.69 | 127.91B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.58 | 49.23B | 5.88B | 1.34B | 799.60M | 2.3489 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Equal-Weight |
| 2025-05-09 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-31 | Downgrade | Goldman | Buy → Sell |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-07-19 | Iniziato | Raymond James | Mkt Perform |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
Mostra tutto
Cytek Biosciences Inc Borsa (CTKB) Ultime notizie
Will Cytek Biosciences Inc. (8EQ) stock top growth indexesWeekly Profit Report & High Accuracy Trade Signal Alerts - ulpravda.ru
Why Cytek Biosciences Inc. stock is a must watch in 20252025 Pullback Review & Community Consensus Trade Signals - ulpravda.ru
Is Cytek Biosciences Inc. stock attractive for retirement portfoliosRisk Management & Technical Confirmation Trade Alerts - ulpravda.ru
What analyst consensus implies for Cytek Biosciences Inc. (8EQ) stockBond Market & Weekly High Return Forecasts - ulpravda.ru
CTKB FinancialsIncome Statement - Quiver Quantitative
User | bentoncourier.comCytek Biosciences, Inc.Common Stock (Nasdaq:CTKB) Stock Quote - FinancialContent
Is Cytek Biosciences (NASDAQ:CTKB) Using Debt In A Risky Way? - 富途牛牛
2026 world cup standings odds: How currency fluctuations impact Cytek Biosciences Inc. stock2026 world cup usa national team round of 16 playmakers transition play match prediction analysis - ulpravda.ru
Cytek Biosciences Inc 8EQ Stock Analysis and ForecastCandlestick Pattern Analysis & Affordable Portfolio Strategies - earlytimes.in
What risks investors should watch in Cytek Biosciences Inc stockGap Down & Free Safe Capital Growth Stock Tips - moha.gov.vn
How currency fluctuations impact Cytek Biosciences Inc. stockStock Screening Results & Big Data Market Reports - bollywoodhelpline.com
Why Cytek Biosciences Inc. (8EQ) stock attracts HNW investorsTrading Psychology Tips & Small Entry Cost Trading - bollywoodhelpline.com
What dividend safety score for Cytek Biosciences Inc. stockLong-Term Investment Plans & Fast Profit Trading Strategies - bollywoodhelpline.com
Cytek Biosciences webinar explores lung cell communication advances - Traders Union
Cytek Biosciences Data Breach Investigation - Claim Depot
Cytek Biosciences Data Breach Exposes Social Security Numbers - Claim Depot
Book value per share of Cytek Biosciences, Inc. – DUS:8EQ - TradingView — Track All Markets
How Cytek Biosciences Inc. stock responds to policy changes2025 Trading Volume Trends & Accurate Buy Signal Alerts - Улправда
Pharma News: How Cytek Biosciences Inc. stock responds to policy changesJuly 2025 Sector Moves & Expert-Curated Trade Recommendations - Улправда
Is Cytek Biosciences Inc. (8EQ) stock a buy on weakness2025 EndofYear Setup & Safe Capital Preservation Plans - DonanımHaber
Is Cytek Biosciences Inc. (8EQ) stock at risk of policy regulationTrade Ideas & High Accuracy Trade Signal Alerts - DonanımHaber
Cytek Biosciences Earnings Notes - Trefis
Cytek Biosciences, Inc. (NASDAQ:CTKB) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Cytek BioSciences Inc (CTKB) expanding its growth trajectory ahead - Setenews
Why Cytek Biosciences Inc. (8EQ) stock stays on buy listsQuarterly Portfolio Report & High Accuracy Buy Signal Tips - Newser
Institutional Owners May Consider Drastic Measures as Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Recent US$58m Drop Adds to Long-term Losses - 富途牛牛
Brown Capital Management LLC Has $24.17 Million Stock Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
Is Cytek Biosciences Inc. stock overvalued by current metricsJuly 2025 EndofMonth & Precise Entry and Exit Recommendations - Newser
Can Cytek Biosciences Inc. stock beat market expectations this quarter - Newser
Can Cytek Biosciences Inc. (8EQ) stock sustain revenue momentumGDP Growth & Safe Capital Growth Plans - Newser
Why Cytek Biosciences Inc. stock attracts global investorsWeekly Trend Report & Fast Gain Stock Tips - Newser
Can Cytek Biosciences Inc. stock maintain operating marginsEarnings Growth Summary & Entry Point Strategy Guides - Newser
Is Cytek Biosciences Inc. (8EQ) stock attractive for dividend growthJuly 2025 Sentiment & Community Verified Trade Alerts - Newser
What is Cytek BioSciences Inc (CTKB) Stock Return on Shareholders’ Capital? - setenews.com
Tranche Update on Cytek Biosciences, Inc.'s Equity Buyback Plan announced on December 30, 2024. - marketscreener.com
Will Cytek Biosciences Inc. (8EQ) stock draw ESG focused funds2025 Fundamental Recap & AI Driven Stock Price Forecasts - Newser
Morgan Stanley Raises Price Target on Cytek Biosciences to $6 From $4, Keeps Equalweight Rating - marketscreener.com
Cytek Biosciences (CTKB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Published on: 2025-12-02 04:27:45 - Newser
Cytek Biosciences Inc Azioni (CTKB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.10%
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):